Your browser doesn't support javascript.
Ivermectin in COVID 19 — promises and prospects
Journal of the Indian Medical Association ; 118(10):86-89, 2020.
Article in English | Scopus | ID: covidwho-1426851
ABSTRACT
Age old anthelmintic drug ivermectin Is showing some promises In the management of COVID 19 patients. In vitro study suggests anti SARS CoV2 viral role of ivermectin but there is some controversy regarding dose selection. Ivermectin has immunomodulatory roie which may be responsible for Its beneficial effects. Though it Is not included in interim COVID 19 management guideline by GOt, but several states like West Bengal, Bihar, UP, Assam have included it in state COVID 19 management guideline. It Is important to be vigilant and more focused to prospectlvely observe the outcome in COVID 19 patients. © 2020, Indian Medical Association. All rights reserved.
Search on Google
Collection: Databases of international organizations Database: Scopus Type of study: Prognostic study Language: English Journal: Journal of the Indian Medical Association Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: Scopus Type of study: Prognostic study Language: English Journal: Journal of the Indian Medical Association Year: 2020 Document Type: Article